Recently it was found that ZnT-8 auto-antibodies are present in 60–80% of new-onset Type 1 diabetes patients [9], and that a polymorphism in the ZnT-8 gene leads to impaired pro-insulin conversion and is associated with Type 2 diabetes [8], [23]. The gene discussed is SLC30A10; the disease is type 1 diabetes mellitus.